Fosamax
Bisphosphonate drugs may not lower cancer risk
- Thu, 06/07/2012 - 2:47pm
A new study shows that bisphosphonate drugs like Fosamax may not lower the risk for colon cancer despite what previous studies have
Take Fosamax and other bisphosphonates for 5+ years and break your thigh bone
- Thu, 05/24/2012 - 11:58am
Bisphosphonate drugs like Fosamax, Reclast, Actonel, and Boniva have been around since the 1990s, but researchers recently questioned how long they should be used.
Health Canada issues bisphosphonate warning
- Thu, 04/05/2012 - 9:17am
- Comments
On December 19th 2011, Health Canada officials issued a warning against use of bisphosphonate drugs including Fosamax®, Actonel®, and other similar bone strengtheni
Merck settles Vytorin® lawsuits, still faces Fosamax lawsuits
- Tue, 03/06/2012 - 2:07pm
- Comments
Drug manufacturer Merck & Co. recently settled an on-going lawsuit with its shareholders who claim the company concealed information about the cholesterol lowering drug Vytorin.
Fosamax® Jaw Decay Lawsuits: Opening statements to be heard
- Thu, 03/01/2012 - 1:52pm
- Comments
Three bellwether trials against drug manufacturer Merck & Co. are scheduled to take place this year.
How the risk for a femur fracture injury can be lowered
- Tue, 02/14/2012 - 10:37am
- Comments
According to a new study the risk for suffering a second femur fracture injury may be lowered when the use of bisphosph
Fosamax®, Boniva®, and Reclast® lawsuits combined into one MDL
- Thu, 02/09/2012 - 10:17am
- Comments
Fosamax, Boniva, and Reclast medications are all included in a class of drugs referred to as “bisphosphonates,” which are designed to strengthen weaken bones.
Three bellwether trials against Merck scheduled for 2012
- Tue, 12/27/2011 - 3:51pm
- Comments
Three bellwether trials are scheduled to take place in 2012 against Merck & Company, manufacturer of the popular bisphosphonate medication known as Fosamax. U.S.
More lawsuits against Merck & Company
- Tue, 12/27/2011 - 3:49pm
- Comments
On December 15, 2011, a Fosamax lawsuit was filed against drug makers Merck & Co.
Fosamax linked to more problems
- Thu, 12/22/2011 - 3:35pm
- Comments
Fosamax, a bisphosphonate drug, was first approved by the Food and Drug Administration (FDA) in 1995 to treat osteoporosis in women.